Nils Anders Haegerstrand

Nils Anders Haegerstrand

Chief Executive Officer at ANNEXIN PHARMACEUTICALS AB
65 year
Health Technology
Consumer Services
Commercial Services

Profile

Nils Anders Haegerstrand is currently the Chief Executive Officer at Annexin Pharmaceuticals AB and the Chief Executive Officer at Spatial Transcriptomics Holding AB. Previously, he worked as the Global Manager at AstraZeneca PLC from 1999 to 2000.
He also held positions as the Manager-Drug Discovery & Development at Karolinska Institutet, the Chief Executive & Scientific Officer at Newron Sweden AB, and the Manager-Drug Discovery & Development at Astra Pain Control AB. Dr. Haegerstrand obtained a doctorate degree from Karolinska Institutet.

Nils Anders Haegerstrand active positions

CompaniesPositionStart
ANNEXIN PHARMACEUTICALS AB Chief Executive Officer 2018-12-31
Chief Executive Officer -

Former positions of Nils Anders Haegerstrand

CompaniesPositionEnd
Chief Executive Officer 2017-05-31
ASTRAZENECA PLC Corporate Officer/Principal 1999-12-31
Astra Pain Control AB
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Nils Anders Haegerstrand's experience

Training of Nils Anders Haegerstrand

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

22

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Health Technology

Astra Pain Control AB

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Nils Anders Haegerstrand